We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

The work tests and revises a 50-year old textbook model, known as the Bloch hypothesis, for the evolution of sterol metabolism in eukaryotic cells. The results indicate that the complexity of sterol ...

Researchers have coaxed stem cells to grow into amniotic sacs filled with fluid 1. The model sacs, which grew to roughly the ...

Researchers have developed a digital laboratory (dLab) system that fully automates the material synthesis and structural, physical property evaluation of thin-film samples. With dLab, the team can ...

RIT biomedical engineering researchers develop new separation technique for lab-on-chip devices to distinguish cells ...

For reasons I’m not sure I fully understand, I like being a test subject in clinical research studies. I once signed up for a study at Mayo Clinic that examined the efficacy of a colon cancer ...

From left, astronomy professor Roger Chevalier, music professor Nicole Mitchell Gantt and biology professor Raymond Keller ...

We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

While taking a very grim view of a teacher holding the hands of female students, the Supreme Court in a most learned, laudable, landmark, logical and latest judgment titled X etc vs Rajesh Kumar & Ors ...

Adelaide Tovar, a postdoctoral geneticist at the University of Michigan, prepares cell samples in a science laboratory on campus ... as she considered the possibility the grant could end up holding ...